ArticleInternational ophthalmology2025
A window into vision health: quality of life and satisfaction among glaucoma patients.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlaucoma is one of the most important causes of irreversible blindness around the world, and it has significant consequences for the vision-related quality of life (QoL) for the patients. There are few studies examining glaucoma patients' subjective experiences-particularly treatment satisfaction and vision-related QoL-in Pakistan and comparable South Asian, resource-limited settings. This study aims to assess the perceived QoL and treatment satisfaction among the glaucoma patients. More emphasis has been given to the impact of glaucoma treatments and their side effects. MATERIALS AND
methodsA cross-sectional study was conducted among 277 glaucoma patients. Participants were recruited from ophthalmology outpatient clinics and completed a structured questionnaire, including the NEI-VFQ-25 (National Eye Institute Visual Function Questionnaire-25), to assess vision-related QoL, questions about treatment satisfaction, side effects, and the affordability of medications. Descriptive statistics were used to summarize demographic data, medical history, and treatment outcomes. Chi-square tests and logistic regression models analyzed associations between treatment satisfaction, side effects, and QoL outcomes.
resultsMost of the patients were very satisfied with their treatment for glaucoma, as in fact, it lowers IOP. Two significant side effects-ocular redness in 29.24% and blurred vision when instigating the drops in 24.19%-had a negative impact on treatment satisfaction and adherence. There was an essential impairment in QoL concerning difficulties with near, distance and side visions. There were socioeconomic issues as well, since 13.36% of the patients reported a difficulty affording medications.
conclusionGlaucoma significantly affects the QoL in patients enrolled in this study. Difficulty with vision and treatment adverse effects remain significant sources of dissatisfaction and non-adherence. The results stress the need for a more holistic, patient-oriented approach in glaucoma management, taking into account the clinical outcomes together with the patient-reported experiences of side effects and economic burdens of the treatment. Addressing all these factors will be essential to improve QoL and treatment adherence in resource-limited settings.
Indexed as
Identifiers
41117987What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.